Nucleai
The leading Spatial Biology Software Platform for Precision Medicine.
105 employees · est. 2018 · Chicago, United States
OncoHost
A technology company transforming the approach to precision medicine for improved patient outcomes.
53 employees · est. 2017 · Binyamina, Israel
OncoHost is the older company (2018 vs 2017).
Side-by-Side Comparison
| Metric | Nucleai | OncoHost |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2017 older |
| Headquarters | ||
| Headquarters | Chicago, United States | Binyamina, Israel |
| Employees | ||
| Employees | 105 | 53 |
| Industry | ||
| Industry | AI, Health Care, Machine Learning | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series C |
| Total Funding | ||
| Total Funding | $60.50M | $52.56M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Spatial Biology, Precision Medicine, AI-powered Technology, Drug Development, Clinical Treatment Decisions, Patient Outcomes, Pharmaceutical Companies, Research Platform, Biomarkers Discovery, Medical Technology | Precision Medicine, Technology Company, PROphet® Platform, Proteomic Pattern Analysis, Non-small Cell Lung Cancer (NSCLC), Immunotherapy Decision-making, Clinical Utility, Biomarker Development, Precision Diagnostics, Plasma-based Testing, Oncology, Patient Outcomes, Entrepreneurial Leadership, Industry Expertise, Clinical Trial |
| Website | ||
| Website | nucleai.ai | oncohost.com |
About Nucleai
Nucleai is a healthcare startup founded in 2017 and headquartered in the United States. The company's slogan, "The leading Spatial Biology Software Platform for Precision Medicine," exemplifies their focus on leveraging AI-powered spatial biology technology to advance precision medicine. Nucleai's e...
About OncoHost
OncoHost is a technology company based in Israel that is revolutionizing the field of precision medicine to enhance patient outcomes. The company's flagship product, PROphet®, utilizes a plasma-based, proteomic pattern analysis to deliver personalized treatment insights for non-small cell lung cance...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Nucleai and OncoHost — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Nucleai and OncoHost — by email.
Frequently Asked Questions
Compare Nucleai with someone else
Start typing a company name or domain.